Why the EU Biotech Act will – and how it must – matter for rare diseases October 2025

Why the EU Biotech Act will – and how it must – matter for rare diseases October 2025 The European Commission is consulting on its forthcoming EU Biotech Act – a flagship initiative of the European Life Sciences Strategy – that aims to strengthen Europe’s capacity to innovate, compete globally, and translate biotechnology into benefits for people and society. https://www.eurordis.org/why-biotech-act-must-matter-rare-diseases/